Dexcel Pharma
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$3.1B
Focus Areas
8
Top Stage
Phase 1/2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Dyne Therapeutics | $3.1B |
| Dexcel Pharma USA | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Dyne Therapeutics | $3.1B |
| Dexcel Pharma USA | — |